Yanqiao Ren

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2025
Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE.

Jiajia Xu, Chao Chen, Yanhua Ye

|Jun 05, 2024
Hepatic arterial infusion chemotherapy combined with toripalimab and surufatinib for the treatment of advanced intrahepatic cholangiocarcinoma.

Songlin Song, Yiming Liu, Yanqiao Ren

|Jan 05, 2023
Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor.

Yusheng Guo, Yanqiao Ren, Feihong Wu

|Nov 10, 2022
Pyogenic liver abscess in non-liver cancer patients and liver cancer patients treated with TACE: Etiological characteristics, treatment, and outcome analysis.

Yi-Ming Liu, Yan-Qiao Ren, Song-Lin Song

|Oct 19, 2022
Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable Progression.

Yanqiao Ren, Ziyi Liu, Joyman Makamure

|Aug 17, 2022
Multimodal Imaging Response after the Singular or Combination Treatments of Vascular Endothelial Growth Factor Inhibitor and Immune Checkpoint Inhibitor.

Yanqiao Ren, Feng Pan, Xuefeng Kan

Pageof 2

Frequent Collaborators

2 joint publications

Lei Chen

2 joint publications

Chuansheng Zheng

1 joint publications

Tao Sun

1 joint publications

Xuefeng Kan